INTRODUCTION
Marek's disease, a widespread lymphoid neoplasm of chickens, is caused by a cell-associated herpesvirus, Marek's disease virus (MDV) . Following exposure to MDV, an early cytolytic infection peaks at 4 to 6 days post-infection (p.i.) when large amounts of viral internal antigen(s) (VIA) can be found in the lymphoid organs. At 6 to 7 days p.i., early immune responses appear, coincident with a switch from cytolytic to latent infection. Latent infection is defined for our purposes as the condition in which the presence of the viral genome can be demonstrated in the absence of viral antigens detected by immunofluorescence (Calnek, 1986) .
It has been shown that immunosuppressive treatments such as administration of cyclosporin, thymectomy coupled with cyclophosphamide treatment, or betamethasone administration, all of which can impair cell-mediated immunity and lymphokine production, affect the latent state (Buscaglia et al., 1988) . Although it appears that there is a link between immunocompetence and initiation and maintenance of latency with MDV, the mechanism(s) is not known. In view of a possible role for lymphokines, this study was undertaken to determine the effect of conditioned medium (CM), a source of cytokines including the lymphokines interleukin 2 (IL-2) and gamma interferon (IFN-2)) (Schauenstein et al., 1982; Pusztai et al., 1986) on MDV latency in vitro. Our experimental system consisted of adding CM to cultures of latently infected spleen cells, which could be expected to enter a cytolytic infection cycle within 24 to 48 h after explantation as demonstrated by VIA expression (Calnek et al., 1982 (Calnek et al., , 1984 .
METHODS
Experimenta! birds. Specific-pathogen-free (SPF) chickens of the P-2a (B 19 B 19) (Weinstock & Sehat, 1987) and S-13 (813 B t3) (Schat et al., 1986) lines were obtained from departmental flocks and were used between 1 and 14 weeks of age. Obese strain chickens (Cole, 1966) were generously provided by Dr R. K. Cole, Department of Poultry and Avian Sciences, Cornell University, Ithaca, N.Y., U.S.A. ; these birds were not from an SPF flock but were hatched and raised in isolation, as were P-2a and S-13 chickens.
Viral inocula. Clone-purified MDV isolates JM-16 (moderate oncogenicity) and RB-1B (high oncogenicity) have been described (Calnek et al., 1984; Schat et al., 1982) . All inocula for these experiments were from stocks of 0000-8437 0 1988 SGM c. BUSCAGLIA AND B. W. CALNEK infected chicken kidney cell cultures stored at -196 °C. The dose was 500 to 1000 p.f.u./bird; inoculation was by intra-abdominal injection.
In vitro cultivation of Intently infected spleen cells. When it was expected that MDV infection of the inoculated chickens had entered latency (8 to 25 days p.i.), spleens were collected aseptically and processed as reported (Calnek et al., 1984) . Lymphocytes were suspended in LM-Hahn medium (Calnek et al., 1981) at a concentration of 5 x 106 cells/ml and incubated in a humidified, 5 % CO2 atmosphere at 41 °C for 24 or 48 h as described (Calnek et al., 1982 (Calnek et al., , 1984 . Smears of cells were prepared at 0 h and after 24 and/or 48 h of incubation and examined for VIA as reported elsewhere (Buscaglia et al., 1988) . Each smear contained the cells from 0.1 ml of culture and the VIA-positive cells were counted.
Production ofCM. Supematant fluids from concanavalin A (Con A)-stimulated chicken spleen cell cultures were produced by methods modified from those described by Schnetzler et al. (1983) and Kr6mer et al. (1984) . Briefly, spleens from 9-to 14-week-old S-13 or Obese strain chickens were collected aseptically, gently forced through a n autoclavable 60 ~tm mesh screen (Tetco, Elmsford, N.Y., U.S.A.), washed and resuspended in pH 7.3 phosphatebuffered saline (PBS). The cells were centrifuged over FicoU-Paque (Pharmacia) and the lymphocytes were collected from the interface. They were washed in PBS and resuspended at a concentration of 2 x 107 cells/ml in LM-Hahn medium.
Con A stimulation
Two different methods were used.
Pulsing. Con A (Sigma) was added at a concentration of 75 ~tg/ml and cells were incubated for 3 h at 41 °C.
The cells were then washed twice and resuspended at 1 x 107 cells/ml in LM base or in LM-Hahn (2%). LM base consisted of a modified LM-Hahn medium without chicken and foetal bovine sera (FBS); LM-Hahn (2%) has been previously described (Schat et al., 1986) and consisted of LM-Hahn medium without FBS, but containing 2 % SPF chicken serum. The cells were incubated for an additional 18 to 24 h at 41 °C, after which they were removed by centrifugation. Supematant fluids were refrigerated after being filtered through a 0.45 ~m membrane filter (Coming Glass Works).
Continuous exposure to red blood cell ( RBC)-bound Con A (RBC-Con A). Heparinized blood was pooled,
washed twice with PBS, diluted to twice the original volume of blood with PBS and centrifuged over Ficoll-Paque. RBC pellets were harvested, washed twice with LM base and suspended in LM-Hahn (2 %) at 5 x 10 s c¢lls/ml. Con A was added to a concentration of 250 ~tg/ml and the cells were incubated at 41 °C for 30 min to allow binding of the mitogen to the cell surface. RBCs were washed four times with LM base and diluted to 2 x 108 cells/ml in LM base or in LM-Hahn (2%). Lymphocyte suspensions and Con A-treated RBCs were combined in equal volumes and incubated at 41 °C for 24 h, after which all cells were removed by centrifugation. The supematant fluids were filtered as above. Before this final filtration, part of some batches were clarified by filtration through an 8 ~tm filter, concentrated 20-fold in a Minitan filter (Millipore) which retains proteins with Mr values above I0000, and pooled. Donor chickens and preparative methods for the various batches of CM used in these experiments are detailed in Table 1 . For CM controls, the following cultures were prepared in parallel with normal CM production by the pulsing and the RBC-Con A methods: (i) spleen cells alone in LM base, (ii) spleen cells and untreated RBCs in LM base and (iii) Con A-RBC alone in LM base. These cells were incubated and centrifuged from the media as ~ described above and supematant fluids were refrigerated after being filtered through a 0.45 ~tm membrane.
Separation oflymphokines. CM, as a source of IL-2 and IFN, was fractionated following a procedure slightly modified from that reported by Fredericksen & Sharma (1986 . Briefly, these two lymphokines wer6 separated by hydropbobic chromatography with the use of phenyl-Sepharose CL-4B (Sigma). Two g of ammonium sulphate and 0.2 ml of I M-Tris-HC1 buffer pH 7.5 were added to 9.8 ml CM. When necessary, CM was clarified by centrifugation. The samples were applied to 15 m[ bed columns equilibrated with 20 raM-Tris-HC1, 20% ammonium sulphate buffer. Unbound proteins were washed from the columns until the absorbance at 280 nm reached zero. This was done with a Retriever IV fraction collector and a UA-5 absorbance/fluorescence detector (Isco), and corroborated by using a spectrophotometer (DU-50; Beckman). The bound proteins were' eluted first with a buffer consisting of 20 mM-Tris-HC1, 20% ammonium sulphate and 10% ethylene glycol, and then with a similar buffer containing 15% ammonium sulphate and 20% ethylene glycol. Aliquots were collected and dialysed for 1 day against PBS in 10 mm x 10 cm dialysis tubing with an Mr cut-offof 10000 (Spectrapore;, Spectrum Medical Industries, Los Angeles, Ca., U.S.A.) and then overnight against LM base. Elution buffers were also dialysed and used as controls. For testing, two pools of aliquots from the unbound proteins were identified as fractions 1 and 2, and two pools of aliquots representing bound proteins eluted with the two buffers were respectively identified as fractions 3 and 4 (see Fig. 1 ). Table 7 ) are easily recognized as being associated with aliquots collected at 0 to 1 h and 4.5 to 6 h, respectively. A third small peak of unknown significance can be seen in aliquots collected at about 3 h. The three peaks had absorbance values (by spectrophotometry) of 2.70, 0-22 and 0-09 respectively. The arrows represent the addition of the buffers to elute bound fractions. Solid lines drawn below the curve indicate the aliquots pooled to make up the four fractions saved from CM D1 + D2 (C) and D6 (C). Aliquots collected during the periods represented by dotted lines were not used in the pools. * CM was concentrated 20-fold (+) or used unconcentrated (-).
medium containing various dilutions of CM. Duplicate or triplicate smears, each representing 0.1 ml of culture, were prepared after 24 and/or 48 h of culture at 41 °C and the VIA-positive cells were counted. LMF activity was considered to be present when the mean number of positive cells in smears from the CM-treated cultures was less than 25~ of that observed in untreated control cultures.
IL-2 microassay. Splenic lymphocytes were incubated in LM-Hahn medium for 48 h at a concentration of 5 x 106 cells/ml with 25 ~tg/ml of Con A. The resultant blast-transformed cells were vigorously shaken, washed twice in PBS and centrifuged over Ficoll-Paque. Those at the interface were harvested, washed again in PBS and resuspended at a final concentration of 1 x 106 cells/ml in LM-Hahn (2~) with HEPES buffer (Buscaglia et al., 1988) and seeded in round bottomed 96-well microtitre plates (Linbro/Titertek, cat. no. 76-242-05) at 0.1 ml/well. Serial dilutions of CM in the same medium were added to triplicate wells at 0.1 ml/well. Medium alone was added to three wells as a control. To provide uniformity, serum-free batches of CM were supplemented with 2~ SPF chicken serum for the test although no significant differences were noted in parallel tests in which those CM batches were not supplemented. . After a I h virus adsorption period, the cultures were drained and overlaid with an agar medium. Neutral red dye was added to stain plaques at 20 h post-inoculation and the plaques were counted 6 h later. The arithmetic mean from duplicate cultures was calculated. The IFN titre of a given sample represented the reciprocal of the highest dilution causing a 50~ reduction in the number of VSV plaques observed in non-IFN-treated controls (Wagner, 1960) .
Statistical analysis. Data were compared for statistical significance by the two-sample rank sum test. Statements of significance are based on a probability level of at least 95~ (Snedecor & Cochran, 1980) .
Experimental design Experiment 1. Six trials were carried out, each with three to five spleen samples, to test various batches of CM for LMF activity. Six batches, C3 (C), C4 (C), D1 + D2 (C), D3, D4 and D5 were examined in one or more of the trials; the three former were concentrated during preparation and therefore were tested at 1:40 to 1:80 dilutions, whereas the three latter batches were not concentrated and were tested at a 1:2 dilution. Details are given in Table 2 .
Experiment 2. This experiment was designed to determine whether the suppressive effect of CM on the expression of VIA in latently infected cells was permanent or depended on the continued presence of CM. Latently infected spleen cells were cultured for 48 h in LM-Hahn medium or in 1 : 2 dilutions of CM batches D3, D4 or D5. VIA-positive cells were counted after 48 h incubation. The three cultures treated with CM were then washed twice with PBS and each split into two; one was resuspended in the original CM-containing medium and the other resuspended in fresh LM-Hahn medium. These cultures were then reincubated for an additional 24 h and again examined for VIA-positive cells.
Experiment 3.
To determine which cells and what conditions were involved in generating LMF in the Con Astimulated spleen cell cultures, S-13 spleen cells from 11-week-old donors were cultured alone without stimulation, or after pulsing with Con A, or were cultured with RBC-Con A or with untreated RBCs. Supernatant fluids collected from those cultures and from a separate culture of only RBC-Con A were tested at a dilution of 1:2 for LMF activity using two samples of latently infected spleen cells. VIA examinations were carried out after 48 h of cultivation.
Experiment 4. LMF activity in CM batch D3 was tested before and after dialysis against LM base using a 10000 Mr cut-off membrane (trial 1) or before and after heating for 5 min at 90, 75, 60 or 45 °C (trial 2). Each sample was used at a dilution of 1 : 2 and was tested against cells from four latently infected spleens in trial 1, or one or two spleens in trial 2. Examinations for VIA were carried out after 48 h.
Experiments 5 and 6. These two experiments were designed to compare levels of IL-2, IFN and LMF in various batches of unconcentrated CM or in fractions of CM collected from the hydrophobic column. Each experiment had two trials. In experiment 5, CM batches A 1, A2, B 1, B2, C 1, C2 and D 1 to D5 were compared. IL-2 titrations were done with dilutions of 1 : 2, 1 : 6, 1 : 18 and 1 : 54. IFN assays were conducted on twofold dilutions from undiluted to 1 : 2048. LMF activity was tested against ceils from a single spleen per trial in 1 : 2 and 1 "50 dilutions (trial 1) or only a 1:2 dilution (trial 2). For experiment 6, CM batches D1 + D2 (trial 1) and D6 (trial 2) were tested for LMF activity at 1 : 2 or 1 : 6 dilutions against cell samples from two spleens in each trial, and for IL-2 and IFN as in experiment 5. An exception was with CM D1 + D2 which was tested at 1 : 10 and 1 : 100 dilutions for IL-2 activity.
RESULTS

Effect of CM on maintenance of MD V latency in vitro
Several different batches of CM, obtained by different methods of Con A stimulation of chicken spleen cells, prevented or markedly reduced the usual expression of VIA when added to cultures of latently infected spleen cells (experiment 1, Table 2 ). Trypan blue dye exclusion tests showed that most of the cells cultivated either in LM-Hahn medium or in the presence of CM were alive, and it was therefore concluded that the CM batches tested were not toxic.
Further proof that the suppressive effect of CM on MDV expression was not mediated through toxicity to the latently infected cells came from experiment 2. Data in Table 3 show that spleen cells in which VIA expression was suppressed by CM for 48 h of cultivation in vitro still had the capacity to 'turn on', since removal of the CM and reincubation for an additional 24 h Table 3 . (73) were free of VIA before cultivation. t CM batches were used at a 1:2 dilution in LM-Hahn medium. Cells were washed twice after 48 h; continued cultivation was in the original CM-containing medium or in LM-Hahn medium alone for an additional 24 h.
* Spleen cells
Effect of temporary (48 h) compared to continuous exposure to CM on VIA expression in cultured MD V latently infected spleen cells (experiment 2)*
:~ ND, Not done.
resulted in the appearance of VIA-positive cells. The results of experiment 3 (see Table 4 ) showed that strong LMF activity in CM was the result of Con A stimulation of spleen cells. CM obtained from spleen cell cultures stimulated either by pulsing with free Con A or by co-cultivation with RBC-Con A was strongly suppressive (no VIA-positive ceils could be detected in tests against two latently infected spleen cell cultures). On the other hand, supernatant fluids from cultures of spleen cells alone or spleen cells cultured with normal RBCs apparently had some suppressive effect on VIA expression (VIA expression rates were 7 to 22 ~ of the expected rates). Supernatant fluids from cultures of RBC-Con A failed to show LMF activity.
Characterization of LMF
Data from experiment 4 (Table 5) showed that LMF was not lost when CM batch D3 was dialysed to exclude constituents with an Mr below 10000, but that heating to 90 °C for 5 min did destroy activity. * All CM batches were tested at a 1 : 2 dilution.
t Reciprocal of the highest dilution to show activity (twofold increase in [3H]thymidine uptake for IL-2 assays; 50% reduction in VSV plaques for IFN assays).
LMF activity is taken as a reduction in the mean number of positive cells by 75 % or more compared with the untreated controls (untreated controls had 111 VIA-positive cells/0.1 ml culture in trial 1 and 48 VIA-positive cells/0.1 ml culture in trial 2); + denotes the presence and -the absence of activity. §* ND, Not done.
The different batches of CM varied greatly in lymphokine content (experiment 5, Table 6 ). Two batches (A2, B2) lacked detectable levels of IL-2, IFN and LMF activity, although this could not be attributed to the method of Con A stimulation since two others (A1, B1) also Trial 1 * Fractions 1 and 2 were unbound; fractions 3 and 4 were bound and then eluted (see Fig. 1 ). t Numbers in parentheses show the number of cells that were VIA-positive as a percentage of the control. :~ LMF was considered to be present when the mean number of VIA-positive cells was less than 25 ~ of that for controls treated with buffer. In Trial 1, there were no controls treated with buffer, so LMF activity could only be presumed when the mean number of VIA-positive cells was less than 25 ~ of that for untreated controls cultures in LM-Hahn medium.
produced by the Con A pulsing method did have detectable levels of two or three of these substances. Similarly, differences were observed between batches of CM produced by stimulation with RBC-Con A when 2~ chicken serum was incorporated in the medium (C1, C2). The most consistent production of IL-2, IFN and LMF resulted from stimulation of spleen cells with RBC-Con A in the absence of serum (D1 to D5). IL-2 titres were considerably higher with those batches than with any of the others, and all five had demonstrable IFN and LMF. Titres of the three substances were not well correlated, although all batches with LMF activity also had IFN.
The results of assays of fractions collected from the hydrophobic columns (experiment 6) are found in Table 7 . Although many sequential aliquots were collected, pools were made to reduce the number of fractions tested to four (see Fig. 1 ). These consisted of early and late fractions representing unbound proteins and fractions representing bound proteins eluted with the two buffers. By comparing the data in Table 7 with the profile shown in Fig. 1 , it is possible to identify peaks presumed to represent IL-2 and IFN, which were respectively found in fractions 2 and 4. In each of the two trials, performed with different batches of CM, two fractions had LMF activity: fraction 1 which was free of detectable IL-2 and IFN, and fraction 4 which was rich in IFN.
DISCUSSION
To our knowledge, this is the first report of regulated expression of MDV VIA, normally associated with a switch to cytolytic infection, following the culture of latently infected lymphocytes. The use of CM was considered as a possible way of maintaining latency in vitro when previous studies (Buscaglia et al., 1988) indicated that treatments known to cause immunosuppression delayed or prevented a switch from cytolytic to latent infection or caused reactivation of cytolytic infection in MDV-infected chickens. These same treatments (cyclosporin, betamethasone administration) are also known to impair the production of lymphokines such as IL-2 or IFN-~ (Cohen et al., 1984; Hall & Goldstein 1982; Nelson, 1984; Besedovsky et al., 1986; Hess et al., 1986) .
The component of CM that is responsible, which we have named LMF, appears to be produced by spleen cells with production greatly enhanced by Con A stimulation. This soluble mediator with an Mr greater than 10000 and susceptible to heat at 90 °C should probably be considered to be a cytokine, but further characterization studies are required.
LMF can be described as having a suppressive effect which requires its continued presence in the medium, since cells could later express VIA after LMF had been removed. However, the mechanism of suppression is unclear. The only conditioned media that showed strong LMF activity were those prepared either with free Con A or with RBC-Con A (Table 4) , supporting the idea that lymphokines miglat be involved with this phenomenon. Some LMF activity could be detected in CM from cultures of spleen cells alone; however, the explanation for this may relate to the presence of cytokines in those cultures as well (Weiler &von B~ilow, 1986 (Weiler &von B~ilow, , 1987 .
CM probably contains many cytokines. IL-2 and IFN are two lymphokines known to be present in the supernatant fluids of Con A-stimulated cultures (Schauenstein et al., 1982; Pusztai et al., 1986) . Our data argue against LMF being IL-2 because their titres were independent of one another. Some batches such as A1 were free of detectable levels of IL-2, but showed LMF activity (Table 6 ). Furthermore, fraction 2 from the hydrophobic column was rich in IL-2 and did not contain LMF (Table 7) . Also, apparently LMF cannot be IFN since LMF was present in the unbound fraction whereas IFN was bound to the hydrophobic column. It may be that in addition to LMF, IFN can also regulate MDV genome expression. IFN-containing CM or CM fractions always had LMF-like activity. Alternatively, yet another suppressive cytokine may be present, which binds to the hydrophobic column and is eluted along with IFN.
The concept of a soluble mediator (cytokine) being involved in the regulation of MDV replication has considerable support from studies on other herpesvirus infections. Establishment and maintenance of herpes simplex virus (HSV) and human cytomegalovirus latency in vitro with the use of drugs alone or in combination with IFN, and with or without changes in the incubation temperature, have been reported (Wigdahl et al., t 982, 1984; Rapp, 1984; Shiraki & Rapp, 1986; Scheck et al., 1986; Cockley & Rapp, 1986) . However, there are conflicting reports on the effect of IFN and other lymphokines on herpesvirus latency. It has been demonstrated that peripheral blood lymphocytes obtained from patients with recurrent disease fail to produce detectable levels of lymphokine activity (Nahmias & Roizman, 1973; Rosenberg et al., 1974; O'Reilly et al., 1977 ; Rasmussen & Merigan, 1978; Green et al., 1981 ; Cunningham & Merigan, 1984; Sheridan et al., 1982) . In a double-blind study of the ability of I FN to prevent reactivation of herpes labialis after surgery involving the trigeminal nerve root, it was concluded that IFN reduces reactivation of latent HSV infection after a potent operative stimulus (Pazin et al., 1979) . Similar results were obtained in vitro and in vivo (Rheinbaben & Schneweis, 1986; Danielescu et al., 1985) . However, Iannello et al. (1987) indicated that IFN does not play a major role in the latency or recurrence of herpes genitalis.
There are suggestions that other factors may be involved in herpesvirus latency. For instance, it was suggested that the resistance of clones of mouse neuroblastoma (C 1300) cells to HSV is due to the production of a non-IFN intracellular inhibitor of HSV replication (Nilheden et al., 1985) . Iwasaka et al. (1983) showed that recurrent lesions from HSV type 2 are associated with the induction of suppressor cells and soluble suppressor factors. More recently Sheridan et al. (1985) suggested that reactivation of latent HSV is associated with the induction of a dialysable factor(s) interfering with IFN and/or IL-2 activity.
From our results it may be concluded that CM contains a lymphokine(s) not related to IL-2 or IFN that helps to maintain MDV latency in vitro. LMF may also regulate genome expression or, alternatively, there may be two soluble independent factors with latency-maintaining activity, both of which are unrelated to IFN. Additional studies are needed to characterize this factor(s) further.
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